In recent years, the guanylate cyclase-C agonists market is anticipated to grow rapidly during the forecast period. According to the United Nations’ World Population Ageing Highlight 2020 study, the worldwide geriatric population is forecast to rise from 727 million in 2020 to 1.5 billion by 2050, a nearly two-fold increase, while the share of the geriatric population in 2020 was about 9.3%, and is expected to rise to 16% by 2050. Geriatric population are at the high risk of gastrointestinal disorders. This lead to the high demand of guanylate cyclase-C agonists in the healthcare sector.
Request For a Sample Copy of This Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-guanylate-cyclase-c-agonists-market
Data Bridge Market Research analyses that the guanylate cyclase-C agonists? market was valued at USD 546 million in 2021 and is expected to reach USD 837.94 million by 2029, registering a CAGR of 5.50% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Constipation associated with irritable bowel syndrome (IBS) and chronic constipation of unclear cause (idiopathic constipation) in adults are treated with guanylate cyclase-C agonists. IBS is characterized by stomach pain or cramps, bloating, and infrequent or difficult bowel movements. Guanylate cyclase-C agonists are prescription pharmaceuticals that can be taken alone or in combination with other drugs.
The rising incidences of gastrointestinal disorders such as chronic idiopathic constipation and irritable bowel syndrome is anticipated to influence the guanylate cyclase-C agonists? market’s growth. Growing smoking addiction and surging alcohol consumption are some of the causes of gastrointestinal disorders. Another significant factor influencing the growth rate of guanylate cyclase-C agonists? market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness will expand the guanylate cyclase-C agonists? market. Additionally, high disposable income and sedentary lifestyle of people will result in the expansion of guanylate cyclase-C agonists? market. Along with this, rising geriatric population and favourable reimbursement policies will enhance the growth rate of the market.
North America dominates the guanylate cyclase-C agonists market because of the well-established healthcare sector in this region. Additionally, growing presence of major key players will further propel the market’s growth rate in this region. Asia-Pacific are expected to grow during the forecast period due to rising healthcare expenditure and improvements in healthcare infrastructure in this region.
Abbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.( Israel), Sanofi (France), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (US), GlaxoSmithKline plc (UK), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Boehringer Ingelheim International GmbH. (Germany), Astellas Pharma Inc. (Japan), Allergan (Ireland), Mitsubishi Tanabe Pharma Corporation (Japan), Kyowa Kirin Co., Ltd.(Japan), Liminal BioSciences Inc. (Canada), Avexegen Therapeutics, Inc.(US), AbbVie Inc. (US)
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475